| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |